Satralizumab

Category: Immunosuppressive



Satralizumab Overview

Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease.[5][6] The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche.[7] The most common side effects include the common cold (nasopharyngitis), headache, upper respiratory tract infection, inflammation of the lining of the stomach...

Read more Satralizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Satralizumab

Recent Satralizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Satralizumab
  • Injection: 120mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Satralizumab or a similar ingredient: (1 result)